StonvexLoading…
StonvexStonvexStonvexCore line items from ABSI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.80M | $4.53M | $5.72M | $4.53M |
Operating Income | $-120.32M | $-108.89M | $-115.52M | $-106.75M |
Net Income | $-115.18M | $-103.11M | $-110.57M | $-104.90M |
EPS (Diluted) | $-0.84 | $-0.94 | $-1.20 | $-1.15 |
Total Assets | $216.30M | $213.61M | $217.30M | $321.01M |
Total Liabilities | $26.85M | $34.48M | $41.12M | $46.59M |
Cash & Equivalents | $20.02M | $41.21M | $72.36M | $59.95M |
Free Cash Flow OCF − CapEx | $-94.03M | $-72.81M | $-65.50M | $-97.51M |
Shares Outstanding | 136.78M | 115.36M | 93.09M | 92.41M |